Table 2.
Subpopulations in the Pentasa or Asacol Groups
| Characteristic | Total | Acid-reducing agents |
P-value | |
|---|---|---|---|---|
| NA | PPIs/H2RAs | |||
| Pentasa group (n = 61) | 27 | 34 | ||
| Sex | 0.80 | |||
| Male | 32 (52.5) | 15 | 17 | |
| Female | 29 (47.5) | 12 | 17 | |
| Age (yr) | 44.8 ± 15.0 | 40.3 ± 13.6 | 52.0 ± 17.9 | 0.17 |
| 50–65 | 8 | 20 | ||
| Duration of disease (yr) | 13.9 ± 8.2 | 11.6 ± 9.3 | 15.8 ± 6.7 | 0.08 |
| ≤ 10 | 12 | 8 | ||
| Disease location | 0.18 | |||
| Total | 33 (54.1) | 18 | 15 | |
| Left-sided | 22 (36.1) | 7 | 15 | |
| Proctitis | 2 (3.3) | 1 | 3 | |
| Asacol group (n = 64) | 38 | 26 | ||
| Sex | 1.00 | |||
| Male | 40 (62.5) | 24 | 16 | |
| Female | 22 (34.3) | 13 | 9 | |
| Age (yr) | 40.5 ± 14.1 | 42.5 ± 13.2 | 37.4 ± 14.7 | 0.16 |
| 50–65 | 14 | 8 | ||
| Duration of disease (yr) | 7.6 ± 6.3 | 6.4 ± 6.0 | 9.4 ± 6.3 | 0.07 |
| ≤ 10 | 25 | 22 | ||
| Disease location | 0.10 | |||
| Total | 31 (48.4) | 15 | 16 | |
| Left-sided | 17 (26.6) | 11 | 6 | |
| Proctitis | 12 (18.8) | 10 | 2 | |
Values are presented as number (%) or mean±standard deviation.
NA, not applicable; PPIs, proton pump inhibitors; H2RAs, H2 receptor antagonists.